Stockreport

Dyne upgraded at Oppenheimer on upcoming trial readout from Avidity [Seeking Alpha]

Avidity Biosciences, Inc.  (RNA) 
PDF target Avidity Biosciences ( RNA ) is set to release this year from a late-stage trial for one of its lead candidates. When the Swiss Recommended For You More Tren [Read more]